European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology最新文献

{"title":"What are the guidelines for immediate breast reconstruction?","authors":"Orit Kaidar-Person, Philip Poortmans, Birgitte Vrou Offersen, Liesbeth J Boersma, Dirk de Ruysscher, Vered Noy, Naama Hermann, Thorsten Kühn","doi":"10.1016/j.ejso.2020.03.226","DOIUrl":"https://doi.org/10.1016/j.ejso.2020.03.226","url":null,"abstract":"","PeriodicalId":519500,"journal":{"name":"European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology","volume":" ","pages":"1214-1215"},"PeriodicalIF":3.8,"publicationDate":"2021-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ejso.2020.03.226","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37908622","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Patients with poor functional walking capacity experience significantly more medical complications post-colorectal surgery than those with higher functional walking capacity.","authors":"Chelsia Gillis, Francesco Carli","doi":"10.1016/j.ejso.2021.02.023","DOIUrl":"https://doi.org/10.1016/j.ejso.2021.02.023","url":null,"abstract":"","PeriodicalId":519500,"journal":{"name":"European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology","volume":" ","pages":"1230-1231"},"PeriodicalIF":3.8,"publicationDate":"2021-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ejso.2021.02.023","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25450864","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"(Mis)understanding the treatment team and the measurement of outcomes in breast reconstruction.","authors":"Brittany Popowich, Xanthoula Kostaras, Carmen Webb, Claire Temple-Oberle","doi":"10.1016/j.ejso.2020.12.012","DOIUrl":"https://doi.org/10.1016/j.ejso.2020.12.012","url":null,"abstract":"","PeriodicalId":519500,"journal":{"name":"European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology","volume":" ","pages":"1228-1229"},"PeriodicalIF":3.8,"publicationDate":"2021-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38836783","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Immediate implant-based breast reconstruction with acellular dermal matrix after conservative mastectomy: can a more effective alternative be used in the near future?","authors":"Gianluca Franceschini, Riccardo Masetti","doi":"10.1016/j.ejso.2020.09.037","DOIUrl":"https://doi.org/10.1016/j.ejso.2020.09.037","url":null,"abstract":"","PeriodicalId":519500,"journal":{"name":"European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology","volume":" ","pages":"1225-1226"},"PeriodicalIF":3.8,"publicationDate":"2021-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ejso.2020.09.037","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38557144","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Corrigendum to 'Soft tissue sarcoma of the hand: Is unplanned excision a problem? [Eur J Surg Oncol 45/7 (2019) 1281-1287].","authors":"Jonathan Lans, Kai-Lou C Yue, René M Castelein, Neal C Chen, Santiago A Lozano-Calderon","doi":"10.1016/j.ejso.2021.02.022","DOIUrl":"https://doi.org/10.1016/j.ejso.2021.02.022","url":null,"abstract":"","PeriodicalId":519500,"journal":{"name":"European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology","volume":" ","pages":"1232"},"PeriodicalIF":3.8,"publicationDate":"2021-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ejso.2021.02.022","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25443010","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Comments on \"Systemic exposure of oxaliplatin and docetaxel in gastric patients with peritonitis carcinomatosis treated with intraperitoneal hyperthermic chemotherapy\".","authors":"Loek A W de Jong, Nielka P van Erp, Philip R de Reuver","doi":"10.1016/j.ejso.2020.09.020","DOIUrl":"https://doi.org/10.1016/j.ejso.2020.09.020","url":null,"abstract":"","PeriodicalId":519500,"journal":{"name":"European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology","volume":" ","pages":"1216-1217"},"PeriodicalIF":3.8,"publicationDate":"2021-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ejso.2020.09.020","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38430455","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"On the need to standardize intraperitoneal chemotherapy.","authors":"Hisham Abdel Mageed","doi":"10.1016/j.ejso.2020.10.024","DOIUrl":"https://doi.org/10.1016/j.ejso.2020.10.024","url":null,"abstract":"","PeriodicalId":519500,"journal":{"name":"European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology","volume":" ","pages":"1227"},"PeriodicalIF":3.8,"publicationDate":"2021-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ejso.2020.10.024","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38552824","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Prognostic significance of skip metastases in NSCLC: Is there a role for histology and preoperative assessment?","authors":"Marco Chiappetta, Filippo Lococo, Alfredo Cesario, Carolina Sassorossi, Dania Nachira, Elisa Meacci, Stefano Margaritora","doi":"10.1016/j.ejso.2020.09.023","DOIUrl":"https://doi.org/10.1016/j.ejso.2020.09.023","url":null,"abstract":"","PeriodicalId":519500,"journal":{"name":"European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology","volume":" ","pages":"1218-1219"},"PeriodicalIF":3.8,"publicationDate":"2021-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38557147","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in association with systemic chemotherapy and bevacizumab, evaluation of safety and feasibility. A single center comparative study.","authors":"Matthieu Siebert,&nbsp;Mohammad Alyami,&nbsp;Frederic Mercier,&nbsp;Colin Gallice,&nbsp;Laurent Villeneuve,&nbsp;Nathalie Laplace,&nbsp;Guillaume Passot,&nbsp;Naoual Bakrin,&nbsp;Olivier Glehen,&nbsp;Vahan Kepenekian","doi":"10.1016/j.ejso.2019.03.021","DOIUrl":"https://doi.org/10.1016/j.ejso.2019.03.021","url":null,"abstract":"<p><strong>Introduction: </strong>Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is a promising technic for unresectable peritoneal metastasis (PM). Targeted therapies such as bevacizumab have demonstrated their efficacy in advanced colorectal and ovarian cancer. We aimed to evaluate the feasibility and safety of this bidimensional therapeutic association.</p><p><strong>Methods: </strong>A prospectively maintained PIPAC database was retrospectively analyzed from December 2015 to March 2018. All patients who underwent PIPAC for unresectable PM were selected. Patients with systemic chemotherapy including bevacizumab (BEVA group) were compared with patients with systemic chemotherapy without bevacizumab (NON-BEVA group). Major morbidity and mortality were analyzed.</p><p><strong>Results: </strong>134 patients underwent 397 PIPAC in Lyon Sud University Hospital. 26 Patients had 88 PIPAC in the BEVA group were compared to 108 patients who had 309 PIPAC in the NON-BEVA group. Patients in the BEVA group demonstrated a higher Peritoneal Cancer Index (PCI 20 vs. 16, p < 0.001). There was no statistical difference in overall 30-day morbidity (BEVA: 13 (14.8%) vs NON-BEVA: 29 (9.4%); p = 0.147). There was no statistical difference for grade III-IV complications (BEVA: 4 (4.5%) vs NON-BEVA 10 (3.2%); P = 0.521). Major complications from BEVA group were as follow, 2 bowel obstructions, one hematoma and one severe hypersensitivity reaction to platinum compound. There was no 30-day mortality in the BEVA group compared to 6 (5.5%) mortality in the NON-BEVA group.</p><p><strong>Conclusion: </strong>PIPAC associated with bevacizumab is feasible, safe and well tolerated. The potential oncologic benefit of the concomitant use of bevacizumab and PIPAC remains to be evaluated.</p>","PeriodicalId":519500,"journal":{"name":"European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology","volume":"47 1","pages":"139-142"},"PeriodicalIF":3.8,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ejso.2019.03.021","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37092852","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Feasibility of diaphragmatic interventions in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: A 20-year experience.","authors":"Fabio Carboni,&nbsp;Orietta Federici,&nbsp;Settimio Zazza,&nbsp;Isabella Sperduti,&nbsp;Mario Valle","doi":"10.1016/j.ejso.2020.08.016","DOIUrl":"https://doi.org/10.1016/j.ejso.2020.08.016","url":null,"abstract":"<p><strong>Introduction: </strong>Complete cytoreductive surgery with hyperthermic intraperitoneal chemotherapy is an effective treatment for improving prognosis of selected patients with peritoneal carcinomatosis. The addiction of diaphragmatic procedures may increase the incidence of postoperative respiratory complications. Our goal was to evaluate the early postoperative results following diaphragmatic surgery.</p><p><strong>Methods: </strong>Prospectively collected data of patients undergoing diaphragmatic surgery between January 2000 and January 2020 were retrospectively analyzed. Chest drains were routinely placed in all cases. Demographics, clinical and perioperative features were evaluated.</p><p><strong>Results: </strong>The study included 222 patients. Peritoneal stripping and full-thickness resections were performed in 165 and 57 cases, respectively. Women and ovarian tumours represented the vast majority of cases. Overall postoperative mortality and morbidity rates were 1.3% (3 patients) and 43.2% (96 patients), respectively. Specific diaphragmatic surgery-related complications was 9.4% (21 patients). No pleural effusion and pneumothotrax occurred. The incidence of pneumonia was 1.8% (4 patients), each due to systemic bacterial origin, 2 (0.9%) of which required Intensive Care Unit-readmission. Postoperative bleeding was observed in 15 (6.7%) cases, 12 (5.4%) of which required reoperation. A comparison with 105 patients who operated during the same period without diaphragmatic surgery was performed and by multivariate analysis, Peritoneal Cancer Index, histology and overall morbidity resulted significantly associated with diaphragmatic surgery.</p><p><strong>Conclusion: </strong>Diaphragmatic surgery during cytoreductive surgery with hyperthermic intraperitoneal chemotherapy is often required in order to obtain complete resection. It may be associated with higher postoperative morbidity, especially bleeding, but routine placement of chest drains may reduce the incidence of adverse respiratory events.</p>","PeriodicalId":519500,"journal":{"name":"European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology","volume":"47 1","pages":"143-148"},"PeriodicalIF":3.8,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ejso.2020.08.016","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38442956","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}